• Korro Bio director Jean Francois Formela reported sales of common stock on June 22-24.
• Total of 171,405 shares sold at weighted average prices of $13.95 to $14.98.
• Indirect holdings fell to 793,328 shares in Atlas Venture Fund XI, L.P. plus 169,556 shares in Atlas Venture Opportunity Fund II, L.P.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Korro Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001030575-26-000004), on June 24, 2026, and is solely responsible for the information contained therein.